44 related articles for article (PubMed ID: 30301315)
1. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U
Front Immunol; 2024; 15():1340619. PubMed ID: 38711498
[TBL] [Abstract][Full Text] [Related]
2. Epitope-distal effects accompany the binding of two distinct antibodies to hepatitis B virus capsids.
Bereszczak JZ; Rose RJ; van Duijn E; Watts NR; Wingfield PT; Steven AC; Heck AJ
J Am Chem Soc; 2013 May; 135(17):6504-12. PubMed ID: 23597076
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus Neutralization with DNA Origami Nanoshells.
Willner EM; Kolbe F; Momburg F; Protzer U; Dietz H
ACS Appl Mater Interfaces; 2024 May; 16(20):25836-25842. PubMed ID: 38728653
[TBL] [Abstract][Full Text] [Related]
4. An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies.
Ahmadi S; Pucca MB; Jürgensen JA; Janke R; Ledsgaard L; Schoof EM; Sørensen CV; Çalışkan F; Laustsen AH
Sci Rep; 2020 Jul; 10(1):10765. PubMed ID: 32612183
[TBL] [Abstract][Full Text] [Related]
5. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21).
Mallery DL; McEwan WA; Bidgood SR; Towers GJ; Johnson CM; James LC
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19985-90. PubMed ID: 21045130
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing hepatitis B.
Robbiani DF
J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32790869
[TBL] [Abstract][Full Text] [Related]
7. Engineering Bacteriophages as Versatile Biologics.
Kilcher S; Loessner MJ
Trends Microbiol; 2019 Apr; 27(4):355-367. PubMed ID: 30322741
[TBL] [Abstract][Full Text] [Related]
8. An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis.
Hemadou A; Laroche-Traineau J; Antoine S; Mondon P; Fontayne A; Le Priol Y; Claverol S; Sanchez S; Cerutti M; Ottones F; Clofent-Sanchez G; Jacobin-Valat MJ
Sci Rep; 2018 Oct; 8(1):15016. PubMed ID: 30302027
[TBL] [Abstract][Full Text] [Related]
9. Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.
Yato K; Onodera T; Matsuda M; Moriyama S; Fujimoto A; Watashi K; Aizaki H; Tanaka T; Moriishi K; Nishitsuji H; Shimotohno K; Tamura K; Takahashi Y; Wakita T; Muramatsu M; Kato T; Suzuki R
J Virol; 2021 Mar; 95(5):. PubMed ID: 33298539
[TBL] [Abstract][Full Text] [Related]
10. Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
Hehle V; Beretta M; Bourgine M; Ait-Goughoulte M; Planchais C; Morisse S; Vesin B; Lorin V; Hieu T; Stauffer A; Fiquet O; Dimitrov JD; Michel ML; Ungeheuer MN; Sureau C; Pol S; Di Santo JP; Strick-Marchand H; Pelletier N; Mouquet H
J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32579155
[TBL] [Abstract][Full Text] [Related]
11. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.
Wang Q; Michailidis E; Yu Y; Wang Z; Hurley AM; Oren DA; Mayer CT; Gazumyan A; Liu Z; Zhou Y; Schoofs T; Yao KH; Nieke JP; Wu J; Jiang Q; Zou C; Kabbani M; Quirk C; Oliveira T; Chhosphel K; Zhang Q; Schneider WM; Jahan C; Ying T; Horowitz J; Caskey M; Jankovic M; Robbiani DF; Wen Y; de Jong YP; Rice CM; Nussenzweig MC
Cell Host Microbe; 2020 Aug; 28(2):335-349.e6. PubMed ID: 32504577
[TBL] [Abstract][Full Text] [Related]
12. Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.
Ma Z; Zhang E; Gao S; Xiong Y; Lu M
Front Immunol; 2019; 10():2308. PubMed ID: 31608073
[TBL] [Abstract][Full Text] [Related]
13. Generation of a Human Monoclonal Antibody to Cross-Reactive Material 197 (CRM₁₉₇) and Development of a Sandwich ELISA for CRM₁₉₇ Conjugate Vaccines.
Kim D; Yoon H; Kim S; Wi J; Chae H; Jo G; Yoon JY; Kim H; Lee C; Kim SH; Hong HJ
J Microbiol Biotechnol; 2018 Dec; 28(12):2113-2120. PubMed ID: 30380821
[TBL] [Abstract][Full Text] [Related]
14. Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy.
França RKA; Studart IC; Bezerra MRL; Pontes LQ; Barbosa AMA; Brigido MM; Furtado GP; Maranhão AQ
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766309
[TBL] [Abstract][Full Text] [Related]
15. A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection.
Burm R; Van Houtte F; Verhoye L; Mesalam AA; Ciesek S; Roingeard P; Wedemeyer H; Leroux-Roels G; Meuleman P
JHEP Rep; 2023 Mar; 5(3):100646. PubMed ID: 36748051
[TBL] [Abstract][Full Text] [Related]
16. Epitope-Paratope Interaction of a Neutralizing Human Anti-Hepatitis B Virus PreS1 Antibody That Recognizes the Receptor-Binding Motif.
Hong J; Choi Y; Choi Y; Lee J; Hong HJ
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358170
[TBL] [Abstract][Full Text] [Related]
17. Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus.
Mobini S; Chizari M; Mafakher L; Rismani E; Rismani E
Front Immunol; 2020; 11():2074. PubMed ID: 33042118
[TBL] [Abstract][Full Text] [Related]
18. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
[No Abstract] [Full Text] [Related]
19. Generation and Characterization of a Neutralizing Human Monoclonal Antibody to Hepatitis B Virus PreS1 from a Phage-Displayed Human Synthetic Fab Library.
Jo G; Jeong MS; Wi J; Kim DH; Kim S; Kim D; Yoon JY; Chae H; Kim KH; Hong HJ
J Microbiol Biotechnol; 2018 Aug; 28(8):1376-1383. PubMed ID: 30301315
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
